StockNews.com initiated coverage on shares of ImmunoGen (NASDAQ:IMGN – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other brokerages have also issued reports on IMGN. Deutsche Bank Aktiengesellschaft initiated coverage on shares of ImmunoGen in a research note on Thursday, […]